Skip to main content
Have a personal or library account? Click to login
Field trial of antibody response to inactivated bacterial vaccine in young Holstein calves: influence of animal health status Cover

Field trial of antibody response to inactivated bacterial vaccine in young Holstein calves: influence of animal health status

Open Access
|Mar 2022

Figures & Tables

Table 1

The number of positive and negative calves following immunisation (a) in each experiment and (b) for each MAL in the first experiment

(a)ExperimentAntibody titreBMINutritional statusOxidative stressPositiveNegative
First7730
H. somniSecond4125
Third2522
First1016
P. multocidaSecond615
Third425
First3770
M. haemolyticaSecond858
Third839
(b)MALPositiveNegativeP value
50384
100451
P. multocida200151-
40030
503160.058
1009280.105
M. haemolytica**20012190.566
4001170.009**
800200.050*

[i] No significant interaction between MAL and the number of positive or negative calves was found for Pasteurella multocida (P = 0.421), but one was found for Mannheimia haemolytica (P < 0.01). H. somniHistophilus somni; MAL – maternal antibody level; * –P < 0.05; ** –P < 0.01

Fig. 1

BMI of the positive and negative group calves at the primary and booster immunisation in the first experiment. * – P < 0.05; ** – P < 0.01; # – P = 0.062

Table 2

The nutritional status in the second experiment (a) and oxidative stress marker values in the third experiment (b)

PositiveNegativePositiveNegativePositiveNegative
Total cholesterolP93.6 ± 5.398.5 ± 5.196.1 ± 4.088.2 ± 13.479.3 ± 8.397.7 ± 4.1
(mg/dL)B118.3 ± 5.2118.6 ± 4.6118.7 ± 3.8114.4 ± 12.8113.8 ± 10.0119.0 ± 3.9
Blood urea nitrogenP12.1 ± 0.710.9 ± 0.411.7 ± 0.510.4 ± 0.613.3 ± 2.311.4 ± 0.5
(mg/dL)B9.3 ± 0.310.4 ± 0.49.6 ± 0.211.4 ± 0.49.3 ± 0.69.8 ± 0.2
Total proteinP5.8 ± 0.1*5.6 ± 0.15.7 ± 0.15.5 ± 0.26.0 ± 0.25.7 ± 0.1
(g/dL)B6.0 ± 0.15.9 ± 0.16.0 ± 0.06.1 ± 0.26.0 ± 0.16.0 ± 0.0
Albumin/globulinP1.04 ± 0.031.08 ± 0.041.05 ± 0.031.11 ± 0.100.91 ± 0.08*1.08 ± 0.02
ratioB1.15 ± 0.031.17 ± 0.031.16 ± 0.021.14 ± 0.081.07 ± 0.031.17 ± 0.02
AlbuminP2.90 ± 0.042.87 ± 0.052.89 ± 0.032.87 ± 0.102.76 ± 0.082.91 ± 0.04
(g/dL)B3.19 ± 0.033.16 ± 0.043.18 ± 0.033.25 ± 0.093.11 ± 0.063.19 ± 0.03
Alpha globulinP1.06 ± 0.021.07 ± 0.031.06 ± 0.021.11 ± 0.071.15 ± 0.081.06 ± 0.02
(g/dL)B0.97 ± 0.020.99 ± 0.020.97 ± 0.021.04 ± 0.050.99 ± 0.030.97 ± 0.02
Beta globulinP1.00 ± 0.030.99 ± 0.031.00 ± 0.020.91 ± 0.061.05 ± 0.070.99 ± 0.02
(g/dL)B1.01 ± 0.021.01 ± 0.021.01 ± 0.011.04 ± 0.051.01 ± 0.051.01 ± 0.01
Gamma globulinP0.81 ± 0.05*0.65 ± 0.060.76 ± 0.040.63 ± 0.120.98 ± 0.15*0.72 ± 0.04
(g/dL)B0.83 ± 0.03*0.75 ± 0.040.80 ± 0.030.79 ± 0.070.92 ± 0.090.78 ± 0.03
PositiveNegativePositiveNegativePositiveNegative
d-ROMsP77.2 ± 2.883.4 ± 2.780.3 ± 2.278.4 ± 3.477.0 ± 5.780.8 ± 2.1
(Carr U)B76.0 ± 1.778.1 ± 2.576.7 ± 1.679.4 ± 5.174.8 ± 2.977.5 ± 1.7
BAPP2,934 ± 502,985 ± 522,959 ± 382,951 ±1142,862 ± 832,978 ± 40
(μM)B2,843 ± 392,802 ± 522,825 ± 332,816 ± 1222,933 ± 852,802 ± 33
P2.64 ± 0.102.81 ± 0.102.73 ± 0.082.66 ± 0.042.69 ± 0.192.73 ± 0.08
OSIB2.69 ± 0.082.82 ± 0.112.74 ± 0.072.85 ± 0.242.57 ± 0.152.79 ± 0.07

[i] H. somniHistophilus somni; P. multocidaPasteurella multocida; M. haemolyticaMannheimia haemolytica; P – at the time of primary immunisation; B – at the time of booster immunisation; * – significant difference (P < 0.05) to the negative

[ii] H. somniHistophilus somni; P. multocidaPasteurella multocida; M. haemolyticaMannheimia haemolytica; P – at the time of primary immunisation; B– at the time of booster immunisation; d-ROMs – diacron reactive oxygen metabolites; Carr U – Carratelli units; BAP – biological antioxidant potential; OSI – oxidative stress index

Table 3

Pearson’s correlation analysis

H.P.M.AtAtH.P.M.
somnimultocidahaemolyticaprimaryboostersomnimultocidahaemolytica
Maternal antibody titreH. somni-
P. multocida0.530**-
M. haemolytica0.438**0.492**-
At primary0.1820.0480.198*-
Body mass indexAt booster0.362**0.298**0.208*0.446**-
H. somni0.1320.1520.1420.316**0.383**-
Post-immunisationP. multocida−0.0330.1320.0850.370**0.347**0.452**-
titreM. haemolytica0.0610.227*0.264**0.389**0.278**0.357**0.510**-
H. somniP. multocidaM. haemolytica
Total cholesterol−0.171−0.093−0.145
Blood urea nitrogen0.1420.101−0.043
Total protein0.593**0.539**0.306*
Albumin/globulin ratio−0.610**−0.485**−0.418**
Albumin−0.068−0.009−0.119
Alpha globulin0.0030.0920.000
Beta globulin0.485**0.303*0.158
Gamma globulin0.766**0.683**0.512**

[i] H. somniHistophilus somni; P. multocidaPasteurella multocida; M. haemolyticaMannheimia haemolytica; Maternal antibody titre – the titre at the primary immunisation; Post-immunisation titre – the titre at three weeks after booster immunisation; * – P < 0.05; ** – P < 0.01

[ii] H. somniHistophilus somni; P. multocidaPasteurella multocida; M. haemolyticaMannheimia haemolytica; Maternal antibody titre – the titre at the primary immunisation; * – P < 0.05; ** – P < 0.01

Fig. 2

Relationship between body mass index at primary immunisation and maternal antibody titre against Histophilus somni at primary immunisation; post-immunisation titre and maternal antibody titre at primary immunisation against H. somni; post-immunisation titre against H. somni and body mass index at primary immunisation; and post-immunisation titre against H. somni and body mass index at booster vaccination in the first experiment (1) and between maternal antibody titre and serum total protein or gamma globulin at the primary immunisation in the second experiment (2). ** – P < 0.01; # – P < 0.10

DOI: https://doi.org/10.2478/jvetres-2022-0003 | Journal eISSN: 2450-8608 (formerly 2300-3235)
Language: English
Page range: 109 - 116
Submitted on: Jul 4, 2021
Accepted on: Jan 11, 2022
Published on: Mar 25, 2022
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services

© 2022 Kazusa Mori, Konosuke Otomaru, Toshihide Kato, Osamu Yokota, Hiromichi Ohtsuka, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.